# Combing a Deep Learning-Based Radiomics With Liquid Biopsy for Preoperative and Non-invasive Diagnosis of Glioma

> **NCT05536024** · — · UNKNOWN · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 500 (estimated)

## Conditions studied

- Glioma (Diagnosis)
- Liquid Biopsy
- Deep Learning

## Interventions

- **DIAGNOSTIC_TEST:** Prediction of glioma grading and molecular subtype

## Key facts

- **NCT ID:** NCT05536024
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-08-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-09-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05536024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05536024, "Combing a Deep Learning-Based Radiomics With Liquid Biopsy for Preoperative and Non-invasive Diagnosis of Glioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05536024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*